ATE554793T1 - Konjugat - Google Patents
KonjugatInfo
- Publication number
- ATE554793T1 ATE554793T1 AT02755200T AT02755200T ATE554793T1 AT E554793 T1 ATE554793 T1 AT E554793T1 AT 02755200 T AT02755200 T AT 02755200T AT 02755200 T AT02755200 T AT 02755200T AT E554793 T1 ATE554793 T1 AT E554793T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptide
- moieties
- therapeutic
- expression vector
- polynucleotide sequence
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 239000013604 expression vector Substances 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 230000003993 interaction Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
- A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0120022.9A GB0120022D0 (en) | 2001-08-16 | 2001-08-16 | Conjugate |
| PCT/GB2002/003813 WO2003015825A2 (en) | 2001-08-16 | 2002-08-16 | Conjugate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE554793T1 true ATE554793T1 (de) | 2012-05-15 |
Family
ID=9920536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02755200T ATE554793T1 (de) | 2001-08-16 | 2002-08-16 | Konjugat |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7655753B2 (de) |
| EP (1) | EP1416970B1 (de) |
| JP (1) | JP2005501853A (de) |
| AT (1) | ATE554793T1 (de) |
| AU (1) | AU2002321496B2 (de) |
| CA (1) | CA2456149A1 (de) |
| GB (1) | GB0120022D0 (de) |
| WO (1) | WO2003015825A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0520436D0 (en) * | 2005-10-07 | 2005-11-16 | Photobiotics Ltd | Biological materials and uses thereof |
| WO2008153725A2 (en) | 2007-05-25 | 2008-12-18 | North Carolina State University | Viral nanoparticle cell-targeted delivery platform |
| GB0904825D0 (en) | 2009-03-20 | 2009-05-06 | Photobiotics Ltd | Biological materials and uses thereof |
| CA2797858A1 (en) | 2010-04-30 | 2011-11-03 | The University Of Western Ontario | Sox9 inhibitors |
| US9095624B2 (en) | 2011-05-23 | 2015-08-04 | Contango Partners Group, Inc. | Modular transport platform for targeted delivery of therapeutic agents |
| GB201416960D0 (en) | 2014-09-25 | 2014-11-12 | Antikor Biopharma Ltd | Biological materials and uses thereof |
| US11795456B2 (en) * | 2018-04-16 | 2023-10-24 | Georgia Tech Research Corporation | MRNA driven expression of RNA editors for treatment of pathologies |
| JP2022086791A (ja) * | 2020-11-30 | 2022-06-09 | 大日本印刷株式会社 | 抗ウイルス性粘着シート |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4671958A (en) * | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| US5851527A (en) * | 1988-04-18 | 1998-12-22 | Immunomedics, Inc. | Method for antibody targeting of therapeutic agents |
| US5135736A (en) | 1988-08-15 | 1992-08-04 | Neorx Corporation | Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
| NZ244306A (en) * | 1991-09-30 | 1995-07-26 | Boehringer Ingelheim Int | Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation |
| US5837533A (en) * | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
| RU2066552C1 (ru) * | 1996-02-12 | 1996-09-20 | Товарищество с ограниченной ответственностью "Био Прогресс" | Композиция для фотодинамического повреждения клеток-мишеней и способ фотодинамического повреждения клеток-мишеней |
| DE19605548A1 (de) * | 1996-02-15 | 1997-09-04 | Boehringer Ingelheim Int | Zusammensetzung für die Transfektion höherer eukaryotischer Zellen |
| US6462070B1 (en) * | 1997-03-06 | 2002-10-08 | The General Hospital Corporation | Photosensitizer conjugates for pathogen targeting |
| US20020137901A1 (en) * | 2001-01-22 | 2002-09-26 | Cavanaugh Philip Gerard | Synthesis, and photodynamic therapy-mediated anti-cancer, and other uses of chlorin e6-transferrin |
| US20020127224A1 (en) * | 2001-03-02 | 2002-09-12 | James Chen | Use of photoluminescent nanoparticles for photodynamic therapy |
-
2001
- 2001-08-16 GB GBGB0120022.9A patent/GB0120022D0/en not_active Ceased
-
2002
- 2002-08-16 JP JP2003520783A patent/JP2005501853A/ja not_active Withdrawn
- 2002-08-16 EP EP02755200A patent/EP1416970B1/de not_active Expired - Lifetime
- 2002-08-16 AT AT02755200T patent/ATE554793T1/de active
- 2002-08-16 AU AU2002321496A patent/AU2002321496B2/en not_active Ceased
- 2002-08-16 WO PCT/GB2002/003813 patent/WO2003015825A2/en not_active Ceased
- 2002-08-16 US US10/485,923 patent/US7655753B2/en not_active Expired - Fee Related
- 2002-08-16 CA CA002456149A patent/CA2456149A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20050234222A1 (en) | 2005-10-20 |
| AU2002321496B2 (en) | 2008-05-29 |
| JP2005501853A (ja) | 2005-01-20 |
| EP1416970B1 (de) | 2012-04-25 |
| US7655753B2 (en) | 2010-02-02 |
| WO2003015825A3 (en) | 2003-07-31 |
| CA2456149A1 (en) | 2003-02-27 |
| GB0120022D0 (en) | 2001-10-10 |
| EP1416970A2 (de) | 2004-05-12 |
| WO2003015825A2 (en) | 2003-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0108173A (pt) | Composições farmacêuticas de toxina de botulina | |
| BR0008688A (pt) | Antagonistas de il-18 recombinantes utilizáveis no tratamento de distúrbios mediados por il-18 | |
| DK0910647T3 (da) | Human DNase i hyperaktive varianter | |
| EA201100072A1 (ru) | Новые композиции и способы | |
| EA201100070A1 (ru) | Туберкулезный белок rv2386c, композиции и их применения | |
| PL2054431T3 (pl) | Konformery adhezyn bakteryjnych | |
| RU2013126581A (ru) | Мутанты стрептокиназы и их ковалентно модифицированные формы | |
| ATE364595T1 (de) | Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika | |
| ATE296312T1 (de) | Metalkomplexbildner | |
| TR200003347T2 (tr) | Neisseria meningitidis'denBASB029 polinükleotidleri ve polipeptidler | |
| ATE554793T1 (de) | Konjugat | |
| WO2008040190A8 (fr) | Petits peptides pour anti-angiogenèse et utilisation de ceux-ci | |
| BRPI0409865A (pt) | injeção intravenosa de ativadores de plasminogênio não neurotóxicos para o tratamento do ataque de apoplexia | |
| BR0009170A (pt) | ácidos nucléicos akt, polipeptìdeos e uso dos mesmos | |
| DE60118359D1 (de) | Humanische pellino-polypeptide | |
| DE602006020562D1 (de) | Hren dafür | |
| WO2004033705A3 (en) | Viral interferon antagonists and uses therefor | |
| JP2004513615A5 (de) | ||
| DE60036469D1 (de) | 17867, eine menschliche aminopeptidase | |
| SE9904289D0 (sv) | Method and camposition for the treatment of adenovairal ocular infections | |
| IL193310A0 (en) | Antibody directed against a polypeptide that interacts with parkin and pharmaceutical compositions comprising the same | |
| TR199902866T2 (xx) | Organo- koruyucu aktiviteye sahip yeni BPC peptid tuzlar�, haz�rlanmalar� ve terapide kullan�lmalar� i�in prosesler. | |
| ATE315041T1 (de) | Salz von morphin-6-glucuronid | |
| DK1156795T3 (da) | Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens | |
| BR0015170A (pt) | Proteìnas de hcv com oxirredução reversìvel e conformação similar à nativa |